CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,000 | -37.5% | 4,239 | -1.3% | 0.00% | – |
| Q2 2022 | $8,000 | -11.1% | 4,296 | -1.6% | 0.00% | – |
| Q1 2022 | $9,000 | -99.7% | 4,365 | -99.6% | 0.00% | -100.0% |
| Q4 2021 | $2,972,000 | -29.7% | 1,096,464 | +15.7% | 0.00% | 0.0% |
| Q3 2021 | $4,226,000 | +143.9% | 947,503 | +217.1% | 0.00% | 0.0% |
| Q2 2021 | $1,733,000 | -55.2% | 298,841 | -45.7% | 0.00% | 0.0% |
| Q1 2021 | $3,864,000 | +27.3% | 550,405 | -13.0% | 0.00% | – |
| Q4 2020 | $3,036,000 | -7.4% | 632,433 | +12.5% | 0.00% | -100.0% |
| Q3 2020 | $3,278,000 | -6.3% | 562,298 | +8.5% | 0.00% | 0.0% |
| Q2 2020 | $3,500,000 | +19.5% | 518,400 | +12.6% | 0.00% | – |
| Q1 2020 | $2,928,000 | -48.4% | 460,424 | -15.4% | 0.00% | -100.0% |
| Q4 2019 | $5,675,000 | -16.6% | 544,261 | -68.6% | 0.00% | 0.0% |
| Q3 2019 | $6,807,000 | -61.8% | 1,731,975 | +44.6% | 0.00% | -71.4% |
| Q2 2019 | $17,813,000 | +241.2% | 1,197,878 | +469.5% | 0.01% | +250.0% |
| Q1 2019 | $5,221,000 | -15.7% | 210,337 | -39.0% | 0.00% | -33.3% |
| Q4 2018 | $6,197,000 | +566.3% | 345,041 | +989.7% | 0.00% | – |
| Q3 2018 | $930,000 | -59.0% | 31,665 | -36.5% | 0.00% | -100.0% |
| Q2 2018 | $2,267,000 | -65.0% | 49,849 | -59.3% | 0.00% | -66.7% |
| Q1 2018 | $6,468,000 | +35.3% | 122,498 | +74.3% | 0.00% | +50.0% |
| Q4 2017 | $4,780,000 | -27.4% | 70,292 | -12.0% | 0.00% | -33.3% |
| Q3 2017 | $6,582,000 | +90.6% | 79,876 | +116.5% | 0.00% | +50.0% |
| Q2 2017 | $3,453,000 | +759.0% | 36,889 | +483.6% | 0.00% | – |
| Q1 2017 | $402,000 | -87.6% | 6,321 | -91.3% | 0.00% | -100.0% |
| Q4 2016 | $3,239,000 | +44.0% | 72,925 | +16.9% | 0.00% | +100.0% |
| Q3 2016 | $2,249,000 | +45.8% | 62,393 | -44.5% | 0.00% | 0.0% |
| Q2 2016 | $1,543,000 | -59.0% | 112,511 | -42.6% | 0.00% | -50.0% |
| Q1 2016 | $3,765,000 | +54.2% | 196,073 | +181.2% | 0.00% | 0.0% |
| Q4 2015 | $2,441,000 | -54.2% | 69,739 | +20.3% | 0.00% | -50.0% |
| Q3 2015 | $5,332,000 | +32.5% | 57,986 | +26.7% | 0.00% | +33.3% |
| Q2 2015 | $4,023,000 | -72.9% | 45,772 | -77.1% | 0.00% | -70.0% |
| Q1 2015 | $14,866,000 | +6.7% | 200,263 | -19.5% | 0.01% | 0.0% |
| Q4 2014 | $13,929,000 | – | 248,739 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,997,826 | $10,834,000 | 0.69% |
| Ikarian Capital, LLC | 1,112,669 | $3,016,000 | 0.45% |
| Versant Venture Management, LLC | 101,855 | $276,000 | 0.15% |
| Virtus ETF Advisers LLC | 60,836 | $165,000 | 0.06% |
| EMFO, LLC | 21,500 | $58,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| PINNACLE ASSOCIATES LTD | 706,336 | $1,914,000 | 0.03% |
| XTX Topco Ltd | 20,920 | $57,000 | 0.03% |
| State of Wyoming | 25,419 | $69,000 | 0.03% |